Learn more about HIV

If you want to learn more about the HIV, Pepe Alcamí, together with a senior researcher of the lab, Mayte Pérez-Olmeda, Josep María Gatell (Head of Infectious Diseases Department at Hospital Clínic in Barcelona until 2016) and José Luis de la Serna (physician and Deputy Director of the Spanish newspaper EL MUNDO) are the authors of the free iPad application “30 years of HIV”. Read more

How can we help you?

The AIDS Immunopathogenesis lab offers a group of patented recombinant viral vectors, HIV-based, with proven utility to evaluate different aspects related to HIV-1 infection: phenotypic determination of viral tropism in clinical samples, titration of neutralizing antibodies, screening and characterization of the antiviral activity of collections of compounds, etc. Read more

Wellcome to the IP Lab

The AIDS Immunopathology Unit was set up in 2000 at Instituto de Salud Carlos III under the leadership of Pepe Alcamí. Our work aims at the comprehension of the pathogenesis of HIV-1, the causal agent of AIDS, and from this knowledge contribute to the development of vaccines and new drugs. Welcome to our group.

Latest news

Transportin 3 Project

We have collected 10.740 € for the Transportin 3 Project in the crowdfunding platform Precipita. We continue collecting money for the research of this protein involved in HIV infection and in a rare muscle disease. Read more

HIVR4P 2018

In the closing ceremony of the HIV Research for Prevention (HIVR4P) conference, held in Chicago in 2016, next edition was announced. HIVR4P 2018 will be held in Madrid in 2018, and the local co-chair will be Dr. Alcamí. Read more

Spanish Aids Research Network (RIS)

The RIS network will be financed for 5 years more. The Coordinator of this new period will be Dr. Alcamí. The RIS has been the best evaluated of the Spanish networks.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.